1. Home
  2. HUBC vs MRKR Comparison

HUBC vs MRKR Comparison

Compare HUBC & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBC
  • MRKR
  • Stock Information
  • Founded
  • HUBC 2017
  • MRKR N/A
  • Country
  • HUBC Israel
  • MRKR United States
  • Employees
  • HUBC N/A
  • MRKR N/A
  • Industry
  • HUBC
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUBC
  • MRKR Health Care
  • Exchange
  • HUBC Nasdaq
  • MRKR Nasdaq
  • Market Cap
  • HUBC 21.7M
  • MRKR 19.1M
  • IPO Year
  • HUBC N/A
  • MRKR N/A
  • Fundamental
  • Price
  • HUBC $2.07
  • MRKR $1.51
  • Analyst Decision
  • HUBC
  • MRKR Strong Buy
  • Analyst Count
  • HUBC 0
  • MRKR 3
  • Target Price
  • HUBC N/A
  • MRKR $13.17
  • AVG Volume (30 Days)
  • HUBC 1.3M
  • MRKR 231.4K
  • Earning Date
  • HUBC 05-01-2025
  • MRKR 08-13-2025
  • Dividend Yield
  • HUBC N/A
  • MRKR N/A
  • EPS Growth
  • HUBC N/A
  • MRKR N/A
  • EPS
  • HUBC N/A
  • MRKR N/A
  • Revenue
  • HUBC $29,562,000.00
  • MRKR $5,696,123.00
  • Revenue This Year
  • HUBC N/A
  • MRKR N/A
  • Revenue Next Year
  • HUBC N/A
  • MRKR $11.28
  • P/E Ratio
  • HUBC N/A
  • MRKR N/A
  • Revenue Growth
  • HUBC N/A
  • MRKR 71.53
  • 52 Week Low
  • HUBC $1.80
  • MRKR $0.95
  • 52 Week High
  • HUBC $14.00
  • MRKR $5.99
  • Technical
  • Relative Strength Index (RSI)
  • HUBC 41.91
  • MRKR 50.81
  • Support Level
  • HUBC $1.80
  • MRKR $1.41
  • Resistance Level
  • HUBC $2.42
  • MRKR $1.53
  • Average True Range (ATR)
  • HUBC 0.28
  • MRKR 0.16
  • MACD
  • HUBC 0.03
  • MRKR -0.03
  • Stochastic Oscillator
  • HUBC 37.66
  • MRKR 9.43

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: